Author

Gary S. Friedman

ANALYSIS OF NON-MELANOMA SKIN CANCER IN THE ULCERATIVE COLITIS PROGRAMME FOR TOFACITINIB

Bruce E. Sands, Millie D. Long, Leonard Baidoo, Walter Reinisch, Julian Panés, Chudy I. Nduaka, Arif Soonasra, Ronald D. Pedersen, Nervin Lawendy, Gary Chan, Gary S. Friedman, Chinyu Su

INTEGRATED SAFETY ANALYSES OF TOFACITINIB IN ULCERATIVE COLITIS CLINICAL TRIALS

William Sandborn, Julian Panés, Geert R. D'Haens, Bruce E. Sands, Chinyu Su, Michele Moscariello, Thomas V Jones, Ron Pedersen, Gary S. Friedman, Nervin Lawendy, Gary Chan

MAINTENANCE OF REMISSION WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS: SUBPOPULATION ANALYSIS FROM AN OPEN-LABEL, LONG-TERM EXTENSION STUDY

Jean-Frederic Colombel, Walter Reinisch, Mark T. Osterman, Andrew J. Thorpe, Chudy I. Nduaka, Haiying Zhang, Nervin Lawendy, Gary S. Friedman, Chinyu Su

PREGNANCY OUTCOMES IN THE TOFACITINIB ULCERATIVE COLITIS OCTAVE STUDIES

Uma Mahadevan, Daniel C. Baumgart, Marla C. Dubinsky, Nervin Lawendy, Gary S. Friedman, Gauree G. Konijeti, Hans Peter Gröchenig, Thomas V Jones, Amy Marren, Andrew J. Thorpe, Chudy I. Nduaka, Chinyu Su

TIME TO LOSS OF EFFICACY FOLLOWING TOFACITINIB INTERRUPTION IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM OCTAVE SUSTAIN

Marla C. Dubinsky, Kofi Clarke, Jochen G. Klaus, Yoram Bouhnik, Arif Soonasra, Andrew J. Thorpe, Haiying Zhang, Gary S. Friedman, Deborah A. Woodworth, Nervin Lawendy, Chinyu Su

TOFACITINIB FOR MAINTENANCE THERAPY IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS IN THE PHASE 3 OCTAVE SUSTAIN TRIAL: RESULTS BY LOCAL AND CENTRAL ENDOSCOPIC ASSESSMENTS

Brian G. Feagan, Severine Vermeire, William Sandborn, Walter Reinisch, Julian Panés, Dino Tarabar, Chinyu Su, Wojciech Niezychowski, Haiying Zhang, Gary S. Friedman, Deborah A. Woodworth, Bruce E. Sands

TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS OF AN OPEN-LABEL, LONG-TERM EXTENSION STUDY WITH UP TO 4.9 YEARS OF TREATMENT

Gary R. Lichtenstein, Edward V. Loftus Jr., Stuart Bloom, Nervin Lawendy, Gary Chan, Gary S. Friedman, Haiying Zhang, Wenjin Wang, Andrew J. Thorpe, Chudy I. Nduaka, Chinyu Su

TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF ULCERATIVE COLITIS: OPEN-LABEL, LONG-TERM EXTENSION STUDY

Gary R. Lichtenstein, Edward V Loftus Jr, Stuart Bloom, Nervin Lawendy, Gary S. Friedman, Haiying Zhang, Wenjin Wang, Andrew J. Thorpe, Chudy I. Nduaka, Chinyu Su

Item 1 - 8 / 8
1